| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet-Derived Growth Factor | 55 | 2005 | 618 | 2.630 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 22 | 2006 | 178 | 1.370 |
Why?
|
| Stem Cells | 22 | 2016 | 3514 | 1.320 |
Why?
|
| Glioma | 21 | 2022 | 3452 | 1.280 |
Why?
|
| Oligodendroglia | 17 | 2019 | 538 | 1.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 20 | 2016 | 1133 | 1.080 |
Why?
|
| Nerve Tissue Proteins | 23 | 2014 | 4408 | 0.970 |
Why?
|
| Astrocytoma | 10 | 2019 | 774 | 0.940 |
Why?
|
| Brain Neoplasms | 26 | 2019 | 9026 | 0.920 |
Why?
|
| Growth Substances | 29 | 1995 | 768 | 0.920 |
Why?
|
| Neuroglia | 6 | 2012 | 954 | 0.900 |
Why?
|
| Proto-Oncogenes | 12 | 1997 | 321 | 0.620 |
Why?
|
| Neural Stem Cells | 4 | 2019 | 887 | 0.610 |
Why?
|
| Population Control | 1 | 2017 | 22 | 0.580 |
Why?
|
| Oncogene Proteins, Fusion | 6 | 2019 | 1608 | 0.560 |
Why?
|
| raf Kinases | 1 | 2017 | 118 | 0.550 |
Why?
|
| Neurons | 17 | 2017 | 9436 | 0.550 |
Why?
|
| Central Nervous System | 4 | 2015 | 1333 | 0.500 |
Why?
|
| Interneurons | 2 | 2017 | 582 | 0.480 |
Why?
|
| Cell Differentiation | 16 | 2016 | 11512 | 0.480 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2014 | 3606 | 0.470 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 287 | 0.470 |
Why?
|
| Gene Expression Regulation | 29 | 2005 | 11874 | 0.460 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2019 | 2057 | 0.440 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 221 | 0.440 |
Why?
|
| 3T3 Cells | 17 | 2013 | 1085 | 0.430 |
Why?
|
| Receptors, Nerve Growth Factor | 7 | 2002 | 198 | 0.420 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2012 | 92 | 0.410 |
Why?
|
| Helix-Loop-Helix Motifs | 5 | 2003 | 96 | 0.410 |
Why?
|
| Protein Multimerization | 1 | 2017 | 982 | 0.390 |
Why?
|
| Genes, Immediate-Early | 3 | 1997 | 102 | 0.380 |
Why?
|
| Animals | 141 | 2022 | 168202 | 0.380 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 9 | 2005 | 1626 | 0.380 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2012 | 332 | 0.360 |
Why?
|
| Phosphorylation | 12 | 2017 | 8311 | 0.360 |
Why?
|
| Mice | 108 | 2019 | 81368 | 0.360 |
Why?
|
| Cerebellum | 2 | 2013 | 1501 | 0.340 |
Why?
|
| Chemokine CCL2 | 6 | 1999 | 602 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2013 | 2821 | 0.330 |
Why?
|
| Transcription Factors | 14 | 2022 | 12116 | 0.320 |
Why?
|
| Proto-Oncogene Proteins | 16 | 2013 | 4512 | 0.310 |
Why?
|
| Phosphotyrosine | 4 | 1997 | 456 | 0.310 |
Why?
|
| Cell Division | 22 | 2000 | 4457 | 0.310 |
Why?
|
| Cells, Cultured | 44 | 2016 | 18937 | 0.290 |
Why?
|
| Cerebral Cortex | 7 | 2005 | 5776 | 0.290 |
Why?
|
| Glioblastoma | 4 | 2015 | 3481 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 8542 | 0.280 |
Why?
|
| Smad Proteins | 1 | 2007 | 156 | 0.270 |
Why?
|
| Transcription, Genetic | 21 | 2001 | 7583 | 0.260 |
Why?
|
| Cell Lineage | 9 | 2011 | 2553 | 0.260 |
Why?
|
| Genome | 3 | 2009 | 1737 | 0.260 |
Why?
|
| Spinal Cord | 8 | 2006 | 1807 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 2916 | 0.250 |
Why?
|
| RNA, Messenger | 25 | 2007 | 12759 | 0.250 |
Why?
|
| Cell Cycle | 19 | 2001 | 2929 | 0.250 |
Why?
|
| Peptides | 12 | 2016 | 4354 | 0.250 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1890 | 0.230 |
Why?
|
| Cloning, Molecular | 11 | 2004 | 4172 | 0.230 |
Why?
|
| Somatomedins | 6 | 1988 | 179 | 0.220 |
Why?
|
| Schwann Cells | 3 | 2001 | 196 | 0.220 |
Why?
|
| Gene Expression Profiling | 9 | 2017 | 9417 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 24 | 2000 | 6188 | 0.220 |
Why?
|
| Chemotactic Factors | 2 | 1995 | 197 | 0.210 |
Why?
|
| DNA-Binding Proteins | 11 | 2014 | 9586 | 0.210 |
Why?
|
| Phosphoproteins | 3 | 2017 | 2445 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2017 | 5672 | 0.210 |
Why?
|
| Homeodomain Proteins | 4 | 2014 | 2413 | 0.200 |
Why?
|
| Neoplastic Stem Cells | 2 | 2022 | 1350 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6126 | 0.200 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 352 | 0.200 |
Why?
|
| Cyclin D1 | 2 | 2001 | 451 | 0.200 |
Why?
|
| DNA Damage | 1 | 2011 | 2445 | 0.180 |
Why?
|
| Gene Expression | 14 | 2001 | 7569 | 0.180 |
Why?
|
| Brain | 10 | 2014 | 27100 | 0.180 |
Why?
|
| Blood Platelets | 16 | 1993 | 2478 | 0.180 |
Why?
|
| Myelin Sheath | 1 | 2004 | 653 | 0.180 |
Why?
|
| Fibroblasts | 18 | 1997 | 4140 | 0.180 |
Why?
|
| Piperazines | 4 | 2009 | 2521 | 0.180 |
Why?
|
| Transfection | 10 | 2003 | 5765 | 0.180 |
Why?
|
| Neocortex | 2 | 2004 | 416 | 0.180 |
Why?
|
| Trans-Activators | 6 | 2013 | 2851 | 0.180 |
Why?
|
| Astrocytes | 6 | 2016 | 1341 | 0.170 |
Why?
|
| Rats | 26 | 2005 | 23716 | 0.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1994 | 790 | 0.170 |
Why?
|
| Cell Survival | 5 | 2014 | 5780 | 0.170 |
Why?
|
| Phosphoserine | 2 | 2017 | 203 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 1962 | 0.160 |
Why?
|
| Oncogenes | 8 | 1986 | 1220 | 0.160 |
Why?
|
| Cues | 2 | 2005 | 875 | 0.160 |
Why?
|
| Pyrimidines | 4 | 2009 | 3027 | 0.160 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1027 | 0.160 |
Why?
|
| Protein Biosynthesis | 9 | 1993 | 2100 | 0.160 |
Why?
|
| Cell Nucleus | 5 | 2014 | 2894 | 0.150 |
Why?
|
| Genes | 9 | 1992 | 1823 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2017 | 10429 | 0.150 |
Why?
|
| Antibodies | 4 | 1997 | 2413 | 0.150 |
Why?
|
| Cell Line | 28 | 1997 | 15577 | 0.150 |
Why?
|
| Telencephalon | 3 | 2003 | 141 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 8 | 2009 | 2425 | 0.140 |
Why?
|
| Signal Transduction | 13 | 2016 | 23415 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 5 | 2011 | 5780 | 0.140 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1463 | 0.140 |
Why?
|
| Casein Kinase II | 1 | 2017 | 122 | 0.140 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
| Receptor, trkB | 2 | 2016 | 124 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2009 | 3533 | 0.130 |
Why?
|
| Organ Culture Techniques | 2 | 2015 | 794 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
| Antibodies, Neoplasm | 1 | 1997 | 280 | 0.130 |
Why?
|
| Hydrocarbons | 1 | 2016 | 105 | 0.130 |
Why?
|
| Interleukin-1 | 4 | 1999 | 1248 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 16968 | 0.130 |
Why?
|
| Simian virus 40 | 7 | 1989 | 291 | 0.130 |
Why?
|
| Pheochromocytoma | 2 | 2010 | 328 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2017 | 1217 | 0.130 |
Why?
|
| DNA | 21 | 1993 | 7196 | 0.130 |
Why?
|
| Enzyme Inhibitors | 3 | 2000 | 3705 | 0.130 |
Why?
|
| Meningioma | 2 | 2009 | 1215 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2017 | 411 | 0.120 |
Why?
|
| Mice, Nude | 10 | 2013 | 3606 | 0.120 |
Why?
|
| Humans | 84 | 2022 | 760740 | 0.120 |
Why?
|
| Immunoblotting | 3 | 2011 | 1646 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1996 | 304 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4569 | 0.120 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 4 | 1999 | 36 | 0.120 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 542 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 933 | 0.120 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 1995 | 117 | 0.120 |
Why?
|
| Phosphopeptides | 3 | 2002 | 240 | 0.110 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 1662 | 0.110 |
Why?
|
| Teratocarcinoma | 1 | 1993 | 16 | 0.110 |
Why?
|
| Mitogens | 6 | 1986 | 229 | 0.110 |
Why?
|
| Animals, Newborn | 4 | 2009 | 2669 | 0.110 |
Why?
|
| Immunoassay | 1 | 1997 | 744 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 655 | 0.110 |
Why?
|
| Molecular Sequence Data | 14 | 2000 | 17630 | 0.110 |
Why?
|
| Receptors, Cell Surface | 8 | 2001 | 2802 | 0.110 |
Why?
|
| Cycloheximide | 8 | 1995 | 343 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2017 | 473 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2006 | 1360 | 0.110 |
Why?
|
| Genes, Dominant | 3 | 1995 | 851 | 0.100 |
Why?
|
| Cell Transformation, Viral | 5 | 2000 | 526 | 0.100 |
Why?
|
| Genes, myc | 1 | 1994 | 390 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2007 | 4392 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 360 | 0.100 |
Why?
|
| Mammals | 4 | 2022 | 1131 | 0.100 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2010 | 732 | 0.100 |
Why?
|
| Calcium Phosphates | 2 | 1992 | 171 | 0.100 |
Why?
|
| Tretinoin | 3 | 1993 | 519 | 0.100 |
Why?
|
| Embryo, Mammalian | 8 | 2014 | 1670 | 0.100 |
Why?
|
| Urogenital System | 1 | 2012 | 88 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2016 | 14388 | 0.100 |
Why?
|
| RNA, Double-Stranded | 3 | 1992 | 294 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1692 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1991 | 1301 | 0.100 |
Why?
|
| Molecular Weight | 7 | 1996 | 2185 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 506 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1336 | 0.100 |
Why?
|
| Xenopus laevis | 3 | 1993 | 963 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 733 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2005 | 8165 | 0.090 |
Why?
|
| Base Sequence | 9 | 1996 | 12420 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 6 | 1989 | 817 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 2011 | 91 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1650 | 0.090 |
Why?
|
| Receptor, trkC | 5 | 1999 | 63 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 1999 | 2863 | 0.090 |
Why?
|
| Interferon Type I | 3 | 1990 | 557 | 0.090 |
Why?
|
| Mutation | 14 | 2022 | 30015 | 0.090 |
Why?
|
| Mutagenesis | 1 | 1995 | 1230 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 852 | 0.090 |
Why?
|
| Amino Acid Sequence | 12 | 2003 | 13442 | 0.090 |
Why?
|
| Blood Physiological Phenomena | 2 | 1989 | 53 | 0.090 |
Why?
|
| Dacarbazine | 2 | 2011 | 559 | 0.090 |
Why?
|
| NF-kappa B | 2 | 1996 | 2481 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2011 | 2625 | 0.090 |
Why?
|
| Macromolecular Substances | 4 | 2003 | 1433 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2019 | 1242 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 370 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2017 | 5034 | 0.090 |
Why?
|
| In Situ Hybridization | 7 | 2012 | 1900 | 0.090 |
Why?
|
| Introns | 1 | 1992 | 968 | 0.090 |
Why?
|
| Nerve Growth Factors | 4 | 1999 | 564 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2011 | 617 | 0.080 |
Why?
|
| Growth Inhibitors | 3 | 2000 | 375 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 18220 | 0.080 |
Why?
|
| Antibody Specificity | 3 | 1997 | 1057 | 0.080 |
Why?
|
| Antineoplastic Agents | 5 | 2013 | 13635 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 1999 | 255 | 0.080 |
Why?
|
| Epidermal Growth Factor | 5 | 1984 | 699 | 0.080 |
Why?
|
| Motor Neurons | 2 | 2006 | 869 | 0.080 |
Why?
|
| Poly I-C | 1 | 1989 | 112 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3599 | 0.080 |
Why?
|
| Kinetics | 9 | 1999 | 6370 | 0.080 |
Why?
|
| COS Cells | 2 | 2016 | 1130 | 0.080 |
Why?
|
| Biological Factors | 1 | 1989 | 157 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 3688 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2004 | 1503 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2020 | 0.080 |
Why?
|
| Recombinant Proteins | 7 | 1999 | 6520 | 0.080 |
Why?
|
| Protein Binding | 3 | 2011 | 9345 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 1999 | 584 | 0.080 |
Why?
|
| Axons | 2 | 1995 | 1671 | 0.070 |
Why?
|
| Benzoquinones | 1 | 2008 | 198 | 0.070 |
Why?
|
| Hedgehog Proteins | 5 | 2003 | 768 | 0.070 |
Why?
|
| Culture Media | 8 | 1990 | 895 | 0.070 |
Why?
|
| Chemokines, CXC | 1 | 1989 | 416 | 0.070 |
Why?
|
| Neoplasms, Experimental | 4 | 1980 | 1226 | 0.070 |
Why?
|
| Plasma | 5 | 1984 | 586 | 0.070 |
Why?
|
| Receptor, erbB-2 | 5 | 1997 | 2553 | 0.070 |
Why?
|
| PC12 Cells | 4 | 2003 | 317 | 0.070 |
Why?
|
| Immunologic Techniques | 2 | 1997 | 212 | 0.070 |
Why?
|
| Blotting, Northern | 4 | 2003 | 1545 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 1 | 2008 | 318 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 814 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 1989 | 1202 | 0.070 |
Why?
|
| Apoptosis | 4 | 2014 | 9476 | 0.070 |
Why?
|
| Organoids | 2 | 1984 | 744 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2896 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 424 | 0.060 |
Why?
|
| Benzamides | 4 | 2009 | 1371 | 0.060 |
Why?
|
| Ethidium | 1 | 2004 | 27 | 0.060 |
Why?
|
| Cuprizone | 1 | 2004 | 12 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 1086 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2007 | 712 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2006 | 803 | 0.060 |
Why?
|
| Mice, Transgenic | 7 | 2014 | 9526 | 0.060 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1984 | 41 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 77 | 0.060 |
Why?
|
| Blood | 5 | 1992 | 596 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2000 | 3607 | 0.060 |
Why?
|
| Electroporation | 2 | 1995 | 233 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 704 | 0.060 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2003 | 34 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6074 | 0.060 |
Why?
|
| Cytokines | 4 | 1992 | 7373 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2011 | 2010 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 3074 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3634 | 0.060 |
Why?
|
| Glycoproteins | 2 | 1989 | 2200 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 22117 | 0.060 |
Why?
|
| Plasmids | 3 | 1987 | 2265 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2703 | 0.060 |
Why?
|
| Oligodendroglioma | 2 | 2004 | 278 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2003 | 239 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2009 | 183 | 0.050 |
Why?
|
| Gastrula | 3 | 1997 | 82 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 1990 | 988 | 0.050 |
Why?
|
| Drug Synergism | 3 | 2011 | 1756 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5863 | 0.050 |
Why?
|
| Genomics | 2 | 2017 | 5822 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2015 | 2509 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 460 | 0.050 |
Why?
|
| Antigens | 2 | 2006 | 1441 | 0.050 |
Why?
|
| Proteins | 5 | 2001 | 6030 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6223 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 3793 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3776 | 0.050 |
Why?
|
| Piperidines | 1 | 2011 | 1655 | 0.050 |
Why?
|
| Body Patterning | 2 | 2003 | 632 | 0.050 |
Why?
|
| Gene Library | 1 | 2005 | 1055 | 0.050 |
Why?
|
| Receptor, trkA | 3 | 1999 | 159 | 0.050 |
Why?
|
| Neurotrophin 3 | 3 | 1999 | 61 | 0.050 |
Why?
|
| Dactinomycin | 5 | 1987 | 304 | 0.050 |
Why?
|
| Multipotent Stem Cells | 1 | 2003 | 200 | 0.050 |
Why?
|
| Dyneins | 1 | 2002 | 124 | 0.050 |
Why?
|
| Medulloblastoma | 2 | 1999 | 677 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2003 | 982 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4269 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1852 | 0.050 |
Why?
|
| Wallerian Degeneration | 2 | 2000 | 68 | 0.050 |
Why?
|
| Axonal Transport | 2 | 2002 | 178 | 0.050 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 1992 | 132 | 0.050 |
Why?
|
| Child | 9 | 2017 | 80089 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2002 | 602 | 0.050 |
Why?
|
| Male | 23 | 2017 | 360402 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2009 | 1245 | 0.040 |
Why?
|
| Genes, Switch | 1 | 2000 | 48 | 0.040 |
Why?
|
| Tetracycline | 1 | 2001 | 216 | 0.040 |
Why?
|
| Gene Rearrangement | 2 | 2016 | 1125 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2012 | 1971 | 0.040 |
Why?
|
| Rats, Inbred WF | 1 | 1999 | 138 | 0.040 |
Why?
|
| Insulin | 3 | 1984 | 6593 | 0.040 |
Why?
|
| Zebrafish Proteins | 2 | 2003 | 1013 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 10754 | 0.040 |
Why?
|
| Teratoma | 3 | 1992 | 404 | 0.040 |
Why?
|
| Binding Sites | 4 | 1999 | 6051 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1987 | 1932 | 0.040 |
Why?
|
| Centrioles | 1 | 1979 | 80 | 0.040 |
Why?
|
| Genes, fos | 1 | 1999 | 175 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2001 | 190 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 697 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2875 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1754 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 3 | 2009 | 368 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2017 | 717 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 3794 | 0.040 |
Why?
|
| Sciatic Nerve | 2 | 2002 | 618 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2000 | 420 | 0.040 |
Why?
|
| Multigene Family | 2 | 2013 | 1076 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2017 | 257 | 0.040 |
Why?
|
| Androstadienes | 1 | 1999 | 348 | 0.040 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 2 | 1989 | 25 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 1989 | 2985 | 0.040 |
Why?
|
| DNA Replication | 7 | 1987 | 1414 | 0.040 |
Why?
|
| Neoplasms | 4 | 2017 | 22131 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 851 | 0.040 |
Why?
|
| SOXE Transcription Factors | 3 | 2001 | 73 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 1990 | 3037 | 0.040 |
Why?
|
| Exons | 2 | 1996 | 2381 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3730 | 0.030 |
Why?
|
| Colorimetry | 1 | 1997 | 150 | 0.030 |
Why?
|
| Somatostatin | 1 | 1979 | 447 | 0.030 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 1996 | 46 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1999 | 412 | 0.030 |
Why?
|
| Vanadates | 1 | 1996 | 82 | 0.030 |
Why?
|
| Child, Preschool | 8 | 2017 | 42193 | 0.030 |
Why?
|
| High Mobility Group Proteins | 3 | 2001 | 177 | 0.030 |
Why?
|
| RNA Probes | 1 | 1996 | 111 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 1996 | 97 | 0.030 |
Why?
|
| Wound Healing | 1 | 1988 | 2802 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 1997 | 326 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2000 | 727 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2000 | 3088 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1141 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 1997 | 205 | 0.030 |
Why?
|
| Tyrosine Transaminase | 2 | 1973 | 11 | 0.030 |
Why?
|
| Hormones | 1 | 1980 | 869 | 0.030 |
Why?
|
| Oocytes | 2 | 1993 | 1166 | 0.030 |
Why?
|
| RNA | 3 | 1997 | 2713 | 0.030 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 213 | 0.030 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2003 | 1768 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 1999 | 3672 | 0.030 |
Why?
|
| Interphase | 3 | 1987 | 227 | 0.030 |
Why?
|
| Phosphothreonine | 1 | 1995 | 62 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 1999 | 3591 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2048 | 0.030 |
Why?
|
| Dimerization | 1 | 2016 | 890 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2010 | 7847 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 328 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 5789 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2000 | 796 | 0.030 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 4110 | 0.030 |
Why?
|
| Adult | 10 | 2010 | 220995 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4739 | 0.030 |
Why?
|
| Female | 18 | 2015 | 392203 | 0.030 |
Why?
|
| Cell Adhesion | 6 | 1995 | 3088 | 0.030 |
Why?
|
| Pregnancy | 4 | 2014 | 29869 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 901 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 851 | 0.030 |
Why?
|
| California | 1 | 1998 | 1431 | 0.030 |
Why?
|
| Base Composition | 1 | 1994 | 290 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2009 | 2261 | 0.030 |
Why?
|
| Rhombencephalon | 2 | 2004 | 81 | 0.030 |
Why?
|
| Pedigree | 2 | 2005 | 4539 | 0.030 |
Why?
|
| Species Specificity | 3 | 1992 | 2410 | 0.030 |
Why?
|
| Neurites | 1 | 1995 | 391 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 489 | 0.030 |
Why?
|
| DNA Primers | 2 | 2009 | 2817 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2014 | 239 | 0.030 |
Why?
|
| Mitosis | 3 | 2000 | 1187 | 0.030 |
Why?
|
| Mesoderm | 2 | 1993 | 674 | 0.030 |
Why?
|
| Phenotype | 3 | 2007 | 16572 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2007 | 310 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1995 | 1519 | 0.030 |
Why?
|
| Microspheres | 1 | 2015 | 782 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1483 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1991 | 777 | 0.020 |
Why?
|
| Prognosis | 5 | 2014 | 29601 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 1995 | 428 | 0.020 |
Why?
|
| Moths | 1 | 1992 | 81 | 0.020 |
Why?
|
| Baculoviridae | 1 | 1992 | 115 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 927 | 0.020 |
Why?
|
| Molecular Biology | 2 | 2012 | 575 | 0.020 |
Why?
|
| Heme | 1 | 2013 | 313 | 0.020 |
Why?
|
| Immune Sera | 1 | 1992 | 605 | 0.020 |
Why?
|
| Permeability | 1 | 2013 | 721 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 925 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9277 | 0.020 |
Why?
|
| Contact Inhibition | 3 | 1981 | 46 | 0.020 |
Why?
|
| Prenylation | 1 | 2011 | 37 | 0.020 |
Why?
|
| Genotype | 3 | 2012 | 12977 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1992 | 509 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11069 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1994 | 685 | 0.020 |
Why?
|
| Microglia | 1 | 2019 | 1357 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 302 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3798 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 251 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 296 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2011 | 357 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1834 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2004 | 3222 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1993 | 572 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 75 | 0.020 |
Why?
|
| Connective Tissue | 2 | 1983 | 419 | 0.020 |
Why?
|
| Prosencephalon | 2 | 2001 | 305 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1992 | 1738 | 0.020 |
Why?
|
| Ectoderm | 2 | 2004 | 137 | 0.020 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 1989 | 59 | 0.020 |
Why?
|
| Research | 1 | 1998 | 1977 | 0.020 |
Why?
|
| Adolescent | 6 | 2015 | 88247 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 1989 | 101 | 0.020 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 1989 | 108 | 0.020 |
Why?
|
| Biological Products | 2 | 1988 | 912 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1987 | 153 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 2803 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 2 | 2001 | 420 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2008 | 1113 | 0.020 |
Why?
|
| Ribosomes | 1 | 1972 | 500 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2639 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2014 | 944 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1989 | 303 | 0.020 |
Why?
|
| Anisomycin | 1 | 1987 | 27 | 0.020 |
Why?
|
| Calcimycin | 1 | 1987 | 213 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1058 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 600 | 0.020 |
Why?
|
| Embryonic Development | 1 | 1992 | 720 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 626 | 0.020 |
Why?
|
| Information Systems | 1 | 1989 | 396 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1901 | 0.020 |
Why?
|
| Clone Cells | 2 | 1989 | 1657 | 0.020 |
Why?
|
| Keratinocytes | 1 | 1991 | 790 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1987 | 100 | 0.020 |
Why?
|
| Solubility | 1 | 1989 | 1089 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1371 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 1999 | 1896 | 0.020 |
Why?
|
| Thymus Gland | 3 | 1976 | 1243 | 0.020 |
Why?
|
| Poly A | 1 | 1987 | 181 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1703 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1987 | 1799 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1825 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 1989 | 365 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2003 | 1989 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1987 | 234 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 123 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 478 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 1386 | 0.020 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1985 | 93 | 0.020 |
Why?
|
| ras Proteins | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 340 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1984 | 31 | 0.020 |
Why?
|
| Blastocyst | 1 | 1988 | 432 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 712 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 2 | 1982 | 865 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 4910 | 0.020 |
Why?
|
| Phalloidine | 1 | 1984 | 21 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 550 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2005 | 313 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2017 | 15908 | 0.010 |
Why?
|
| Capsid | 1 | 1987 | 433 | 0.010 |
Why?
|
| Databases, Nucleic Acid | 1 | 2005 | 205 | 0.010 |
Why?
|
| Synapses | 1 | 2014 | 1754 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1984 | 190 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 343 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 455 | 0.010 |
Why?
|
| Vaccination | 1 | 1976 | 3370 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1989 | 718 | 0.010 |
Why?
|
| Isoquinolines | 2 | 1995 | 352 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 20077 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 662 | 0.010 |
Why?
|
| Chordata, Nonvertebrate | 1 | 1982 | 14 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 2644 | 0.010 |
Why?
|
| Kidney | 2 | 2012 | 7044 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2004 | 333 | 0.010 |
Why?
|
| Invertebrates | 1 | 1982 | 55 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 158 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3868 | 0.010 |
Why?
|
| Hydrocortisone | 3 | 1984 | 1819 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1982 | 366 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 2747 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2812 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2002 | 107 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 73 | 0.010 |
Why?
|
| Retina | 1 | 1993 | 2655 | 0.010 |
Why?
|
| Time Factors | 5 | 2011 | 39908 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 317 | 0.010 |
Why?
|
| Stimulation, Chemical | 2 | 1999 | 306 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1662 | 0.010 |
Why?
|
| Lymphocyte Activation | 3 | 1988 | 5463 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1991 | 3680 | 0.010 |
Why?
|
| Endonucleases | 1 | 1984 | 371 | 0.010 |
Why?
|
| Feedback | 1 | 1985 | 790 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1981 | 108 | 0.010 |
Why?
|
| Alleles | 1 | 2013 | 6861 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 1415 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2001 | 36 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18381 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1981 | 422 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2063 | 0.010 |
Why?
|
| Growth | 1 | 1983 | 365 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1981 | 276 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2001 | 98 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1981 | 277 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1984 | 754 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2000 | 2456 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1984 | 802 | 0.010 |
Why?
|
| Ouabain | 1 | 1980 | 247 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1984 | 927 | 0.010 |
Why?
|
| Testis | 1 | 2003 | 792 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1982 | 562 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 692 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2000 | 241 | 0.010 |
Why?
|
| Phorbols | 1 | 1979 | 43 | 0.010 |
Why?
|
| Cyclin E | 1 | 2000 | 155 | 0.010 |
Why?
|
| Calcium Pyrophosphate | 1 | 1979 | 55 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3837 | 0.010 |
Why?
|
| Micropore Filters | 1 | 1979 | 22 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2004 | 999 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2178 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 251 | 0.010 |
Why?
|
| Cations | 1 | 1980 | 238 | 0.010 |
Why?
|
| Middle Aged | 6 | 2010 | 220603 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1979 | 114 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 1999 | 131 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3193 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3589 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1999 | 94 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2013 | 41464 | 0.010 |
Why?
|
| Infant | 3 | 2015 | 36157 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 287 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 1235 | 0.010 |
Why?
|
| Thalamus | 1 | 2004 | 1047 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1980 | 268 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 364 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6305 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2000 | 431 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1979 | 555 | 0.010 |
Why?
|
| Aged | 4 | 2010 | 169092 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 472 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2286 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 476 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1983 | 1070 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2001 | 741 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2000 | 525 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 1140 | 0.010 |
Why?
|
| K562 Cells | 1 | 1999 | 641 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1987 | 3392 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26183 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1980 | 635 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 237 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1979 | 573 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1997 | 361 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1993 | 2382 | 0.010 |
Why?
|
| Potassium | 1 | 1980 | 1311 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2006 | 1910 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2000 | 960 | 0.010 |
Why?
|
| Tin Compounds | 1 | 1995 | 8 | 0.010 |
Why?
|
| Methylation | 1 | 1999 | 1077 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 17878 | 0.010 |
Why?
|
| Indium | 1 | 1995 | 47 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1984 | 2202 | 0.010 |
Why?
|
| Glycosylation | 1 | 1999 | 1098 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 1999 | 471 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2000 | 566 | 0.010 |
Why?
|
| Catalysis | 1 | 1997 | 773 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2000 | 13383 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1980 | 988 | 0.010 |
Why?
|
| Cilia | 1 | 1979 | 492 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 12719 | 0.010 |
Why?
|
| Glass | 1 | 1995 | 115 | 0.010 |
Why?
|
| Enzyme Induction | 2 | 1973 | 452 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1979 | 1056 | 0.010 |
Why?
|
| Phylogeny | 1 | 1982 | 2805 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 11118 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1995 | 405 | 0.010 |
Why?
|
| Acetylation | 1 | 1997 | 1055 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1490 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1999 | 1687 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14649 | 0.010 |
Why?
|
| Cattle | 1 | 1980 | 3841 | 0.010 |
Why?
|
| Leucine | 2 | 1973 | 548 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1993 | 192 | 0.010 |
Why?
|
| B-Lymphocytes | 2 | 1984 | 4745 | 0.010 |
Why?
|
| Biotechnology | 1 | 1995 | 281 | 0.010 |
Why?
|
| Nervous System | 1 | 1997 | 545 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1999 | 1743 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1988 | 10175 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1624 | 0.010 |
Why?
|
| Liver | 2 | 2003 | 7512 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 4919 | 0.010 |
Why?
|
| Methotrexate | 1 | 1979 | 1716 | 0.010 |
Why?
|
| Genome, Human | 1 | 2005 | 4421 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 2137 | 0.010 |
Why?
|
| Puromycin | 1 | 1972 | 42 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1972 | 184 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1994 | 749 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1980 | 1985 | 0.010 |
Why?
|
| Glutaral | 1 | 1991 | 76 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1065 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1972 | 861 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 2872 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 458 | 0.010 |
Why?
|
| Half-Life | 1 | 1972 | 650 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 4403 | 0.010 |
Why?
|
| Dendrites | 1 | 1993 | 471 | 0.010 |
Why?
|
| Computers, Mainframe | 1 | 1989 | 2 | 0.010 |
Why?
|
| Minicomputers | 1 | 1989 | 10 | 0.010 |
Why?
|
| Cricetinae | 2 | 1986 | 2424 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1991 | 750 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 58919 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1993 | 905 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 7963 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 14024 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 1989 | 111 | 0.000 |
Why?
|
| Models, Biological | 1 | 2005 | 9461 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12966 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4947 | 0.000 |
Why?
|
| Computer Systems | 1 | 1989 | 469 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 3394 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15250 | 0.000 |
Why?
|
| Keratins | 1 | 1989 | 498 | 0.000 |
Why?
|
| Mice, Mutant Strains | 1 | 1991 | 1748 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1993 | 1112 | 0.000 |
Why?
|
| Viral Structural Proteins | 1 | 1987 | 95 | 0.000 |
Why?
|
| Epidermis | 1 | 1989 | 526 | 0.000 |
Why?
|
| Densitometry | 1 | 1986 | 151 | 0.000 |
Why?
|
| Mesocricetus | 1 | 1986 | 252 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1997 | 2565 | 0.000 |
Why?
|
| Fibrinogen | 2 | 1979 | 887 | 0.000 |
Why?
|
| Swine | 1 | 1995 | 5908 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1991 | 2340 | 0.000 |
Why?
|
| Lung | 1 | 2003 | 9999 | 0.000 |
Why?
|
| Cell Communication | 1 | 1991 | 1654 | 0.000 |
Why?
|
| United States | 1 | 2011 | 72292 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 64572 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1973 | 2292 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1976 | 4438 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1994 | 10072 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5319 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9171 | 0.000 |
Why?
|
| Liver Neoplasms | 2 | 1973 | 4309 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1979 | 299 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1979 | 531 | 0.000 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1980 | 477 | 0.000 |
Why?
|
| Glucuronidase | 1 | 1979 | 202 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1977 | 139 | 0.000 |
Why?
|
| Amino Acids | 1 | 1980 | 1718 | 0.000 |
Why?
|
| Enzyme Repression | 1 | 1973 | 30 | 0.000 |
Why?
|
| Deoxyadenosines | 1 | 1973 | 27 | 0.000 |
Why?
|
| Tritium | 1 | 1973 | 706 | 0.000 |
Why?
|
| RNA, Ribosomal | 1 | 1973 | 227 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1979 | 1438 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1973 | 561 | 0.000 |
Why?
|
| Adenosine | 1 | 1973 | 805 | 0.000 |
Why?
|